111 related articles for article (PubMed ID: 6148118)
21. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
Honer WG; Kopala LC; Rabinowitz J
J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
[TBL] [Abstract][Full Text] [Related]
22. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
23. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
Woggon B
Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
[TBL] [Abstract][Full Text] [Related]
24. [Initial experience with the neuroleptic Zetidoline in hospitalized schizophrenic patients].
Zapletálek M; Libiger J; Tůma I
Cesk Psychiatr; 1983 Apr; 79(2):83-8. PubMed ID: 6134590
[No Abstract] [Full Text] [Related]
25. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
26. Savoxepine versus haloperidol. Reasons for a failed controlled clinical trial in patients with an acute episode of schizophrenia.
Volz HP; Möller HJ; Gerebtzoff A; Bischoff S
Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):76-80. PubMed ID: 12111340
[TBL] [Abstract][Full Text] [Related]
27. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the clinical effects of timiperone, a new butyrophenone derivative, and haloperidol on schizophrenia using a double-blind technique.
Kariya T; Shimazono Y; Itoh H; Mori A; Murasaki M; Sugano K; Toru M; Yamashita I
J Int Med Res; 1983; 11(2):66-77. PubMed ID: 6133803
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
Wynchank D; Berk M
Hum Psychopharmacol; 2003 Jun; 18(4):271-5. PubMed ID: 12766931
[TBL] [Abstract][Full Text] [Related]
30. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
de Haan L; van Bruggen M; Lavalaye J; Booij J; Dingemans PM; Linszen D
Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
[TBL] [Abstract][Full Text] [Related]
31. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Eklund K; Forsman A
Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
[TBL] [Abstract][Full Text] [Related]
32. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
Cassano GB; Castrogiovanni P; Conti L; Bonollo L
Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
[No Abstract] [Full Text] [Related]
33. A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients.
Bechelli LP; Ruffino-Netto A; Hetem G
Braz J Med Biol Res; 1983 Dec; 16(4):305-11. PubMed ID: 6143579
[TBL] [Abstract][Full Text] [Related]
34. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
Delcker A; Schoon ML; Oczkowski B; Gaertner HJ
Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
[TBL] [Abstract][Full Text] [Related]
35. Risperidone in treatment-refractory schizophrenia.
Wirshing DA; Marshall BD; Green MF; Mintz J; Marder SR; Wirshing WC
Am J Psychiatry; 1999 Sep; 156(9):1374-9. PubMed ID: 10484947
[TBL] [Abstract][Full Text] [Related]
36. Olanzapine versus haloperidol treatment in first-episode psychosis.
Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
[TBL] [Abstract][Full Text] [Related]
37. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
[TBL] [Abstract][Full Text] [Related]
38. [Zetidoline in the treatment of schizophrenia--initial experiences].
Molcan J; Korínková V; Koníková M; Rakús A; Pribyl R
Cesk Psychiatr; 1984 Jun; 80(3):143-5. PubMed ID: 6148151
[No Abstract] [Full Text] [Related]
39. Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia.
Docherty JP; Baker RA; Eudicone J; Mathew S; Marcus RN; McQuade RD; Mankoski R
Schizophr Res; 2010 Jul; 120(1-3):199-203. PubMed ID: 20547037
[TBL] [Abstract][Full Text] [Related]
40. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]